title: Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
abstract: The aim of this study was to evaluate the effect of an oral glucose tolerance test (OGTT) on the level of endothelial dysfunction and vascular inflammation markers in healthy subjects (H) and diabetic overweight patients (D). We enrolled 256 healthy subjects and 274 type 2 diabetic patients. We evaluated blood glucose (BG), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-6 (IL-6), high-sensitivity C reactive protein (hsCRP), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), and tumor necrosis factor-alpha (TNF-alpha) at baseline and after OGTT. We observed that BG, sICAM-1, IL-6, hs-CRP, sVCAM-1, sE-selectin, and TNF-alpha values were higher in D group than in H group. In a large sample of adult healthy subjects and type 2 diabetics we observed that both answer to an OGTT with a significant increase in biomarkers of systemic low-grade inflammation and endothelial dysfunction such as hsCRP, IL-6, TNF-alpha, sICAM-1, sVCAM-1, and sE-selectin. Type 2 diabetics experienced, however, a more significant increase in TNF-alpha, and sE-selectin.
authors.affiliation: Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S. Matteo, P. le C. Golgi 2, 27100 Pavia, Italy. giuseppe.derosa@unipv.it
authors.forename: G
authors.initials: G
authors.lastname: Derosa
authors.forename: A
authors.initials: A
authors.lastname: D'Angelo
authors.forename: S A T
authors.initials: SA
authors.lastname: Salvadeo
authors.forename: I
authors.initials: I
authors.lastname: Ferrari
authors.forename: E
authors.initials: E
authors.lastname: Fogari
authors.forename: A
authors.initials: A
authors.lastname: Gravina
authors.forename: R
authors.initials: R
authors.lastname: Mereu
authors.forename: I
authors.initials: I
authors.lastname: Palumbo
authors.forename: P
authors.initials: P
authors.lastname: Maffioli
authors.forename: S
authors.initials: S
authors.lastname: Randazzo
authors.forename: A F G
authors.initials: AF
authors.lastname: Cicero
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood*; D001786:Blood Glucose; D002097:C-Reactive Protein / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000276:immunology*; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000276:immunology; D004727:Endothelium / Q000276:immunology*; D004730:Endothelium, Vascular / Q000276:immunology*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; D002097:C-Reactive Protein